Missing/wrong data?
Log in to edit
Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study
scientific article published in 2012
Author/s
author: Amitava Banerjee, Christian Torp-Pedersen, Deirdre A Lane, Gregory Lip
Work details
Publication date
2012
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.